Professor Karen Canfell
Director, Cancer Research Division, Cancer Council NSW; Adjunct Professor, Sydney Medical School, University of Sydney (Australia)
Professor Karen Canfell is Director of the Cancer Research Division at Cancer Council NSW and Adjunct Professor at Sydney Medical School, University of Sydney. She holds a D.Phil. (PhD equivalent) in Epidemiology from the University of Oxford. Her work involves the evaluation and translation of new strategies for cancer screening. A focus has been the interplay between HPV vaccination and cervical screening in both high and low resource countries. She has led economic evaluations of new cervical screening approaches for government and her group’s work also underpins the current Renewal (review) of the National Cervical Screening Program in Australia. In collaboration with the Victorian Cytology Service, she initiated Compass, which is Australia’s largest clinical trial to assess cervical screening in an HPV-vaccinated population. In addition to work on new approaches to breast screening, she has active projects to quantify the benefits, harms and cost-effectiveness of the National Bowel Cancer Screening Program, to evaluate screening for Lynch Syndrome, and to assess potential new strategies for PSA testing and lung cancer screening. In 2015, Karen received the National Research Excellence Award for the highest-ranked Career Development Fellowship in Population Health and was nominated as one of ‘100 Women of Influence’ in the Westpac/Australian Financial Review national awards.
Professor Sophia Zackrisson
Senior Consultant Radiologist, Skåne University Hospital; Associate Professor and Senior Lecturer in Radiology, Lund University (Sweden)
Professor Sophia Zackrisson, MD, PHD is senior consultant radiologist at Skåne University Hospital in Malmö and Associate Professor and Senior Lecturer in Radiology at Lund University, Sweden. She was awarded her PhD in epidemiology in 2006. The thesis was focused on epidemiological aspects of mammography screening. She has since then initiated several clinical and epidemiological studies within cancer imaging, with breast cancer as the main topic. Metastatic disease and colorectal cancer are other areas of interest. In 2011, Zackrisson had a post doc position in molecular imaging at the Gambhir Lab, Stanford University, Ca, USA, working on photoacoustic cancer imaging. She is an internationally renowned speaker and author of numerous scientific papers and book chapters. Zackrisson is research group leader in cancer imaging at Lund University and since 2009 PI of the Malmö Breast Tomosynthesis Screening Trial, MBTST. The MBTST is a prospective, population based screening trial of 15,000 women, set to investigate the use of digital breast tomosynthesis in screening.
Professor Andrew Evans
Andy Evans is professor of breast imaging at Dundee University. He is a world leading authority on shear-wave elastography of the breast. Other fields of expertise include breast cancer screening and ductal carcinoma in situ. He is a past chairman of the British society of Breast Radiology, a member of the scientific committee of the European Society of Breast Imaging and a member of Breast Imaging subcommittee of the European Congress of Radiology. He has research outputs include over 160 peer reviewed publications, 17 book chapters and 3 books. He also plays the French horn and is a successful composer of classical music.
Mandy Simpson is a professional director, consultant and keynote speaker with a particular focus on the business and human impacts of fast moving technologies. Over the past decade, Mandy has held senior financial and operational roles in the New Zewaland government and private sector including Chief Operating Officer at the New Zealand Stock Exchange and most recently Chief Executive at cybersecurity consultancy Cyber Toa. Mandy is a faculty member at Singularity University, a Silicon Valley based think tank devoted to studying and educating about how different technologies will affect the world. Originally from the UK, Mandy has a law degree from Cambridge University. She is a Fellow of the Institute of Chartered Accountants in England and Wales, a member of the New Zealand Institute of Directors and a member of New Zealand Global Women.
Dr Jennifer Stone, Senior Research Fellow
Jennifer Stone is an NBCF-funded Fellow at the Centre for Genetic Origins of Health and Disease at The University of Western Australia. Jennifer started out as a statistician with Dr Norman Boyd at the Ontario Cancer Institute in Toronto, Canada and went on to complete her PhD at the University of Melbourne under the supervision of Prof John Hopper which examined the genetic and environmental determinants of mammographic density, one of the strongest and most common risk factors for breast cancer. Post-PhD she completed a 1-year post doc at the Cancer Research UK Centre for Epidemiology, Mathematics & Statistics investigating mammographic density and in women in the International Breast Cancer Intervention Study I (IBIS-1), a trial of tamoxifen for breast cancer prevention, under the direction of Prof Jack Cuzick. Jennifer is currently establishing her own research team at UWA where she is leading two nationally funded grants investigating mammographic density in Western Australian Aboriginal women as well as novel measures of breast density in young women. She is also involved with several international projects investigating the genetic determinants of mammographic density as a strong and highly heritable intermediate phenotype for breast cancer risk. Jennifer’s research aims to support accumulating evidence for the clinical use of mammographic density to improve breast cancer screening.